Global Crisaborole Market Overview:
Crisaborole is a topical drug used for skin treatment in mild-to-moderate atopic dermatitis, eczema. It is non Steroidal medication by nature, which works by blocking a certain substance in the body which harms or introduces the inflammation symptoms. Crisaborole topical mostly used on the skin treat mild in adults and children who are at least 2 years old. Some of the key players profiled in the study are Pfizer (United States), Synergy Pharmaceuticals (United States), Ansun Biopharma (United States), Tapi api Pharmaceuticals (Israel), Viruj pharmaceuticals (India), Glenmark Pharmaceuticals (India), Incepta Pharmaceuticals (Bangladesh), Biophore (India), UQUIFA Pharmaceuticals (Spain) and Cipla (India).
On the basis of geography, the market of Crisaborole has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End Users, the sub-segment i.e. Hospitals will boost the Crisaborole market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Distribution Channel, the sub-segment i.e. Online Stores will boost the Crisaborole market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Packaging , the sub-segment i.e. 15 Mg Tube will boost the Crisaborole market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Drivers
- Highly Used as it Reduces Swelling, Redness, and Itching on the Skin
- First Approved Medication for Children for Allergic Dermatitis
Market Trend
- Growing Used for Children Who are at least 2 Years Old
Restraints
- It can cause Burning or Stinging at the Application Site
- May Cause Another Skin Irritation to Sensitive Individual
Opportunities
- Growing Skin Diseases Like Dermatitis, Eczema, etc.
Challenges
- High Cost is Associated with Product
- Excess Use Increased Risk of Cancer
Major Market Developments:
On 17th June 2019, Pfizer acquired Array Biopharma which will increase the biopharmaceutical business of the Pfizer. The transaction was done in cash of USD 48 shares for the total value of the organization approximately USD 11.4 billion.
On 23 January 2020, Pfizer VACCINES launched global vaccines division center for an excellent network to conduct real-world research on vaccine-preventable diseases affecting adults. It is the first center of excellence with a second global center in 2020.
U.S. Food and Drug Administration on Dec 14, 2016, approved Crisaborole ointment 2% a novel non-steroidal topical medication for patients 2 years age and older. First prescription treatment approved for allergic dermatitis and eczema in lat decades.
The growing skin disease increasing the demand of various ointments like Crisaborole. There are only a few firms in the market that manufactures this product therefore there is moderate competition. The drug is recently approved by the FDA after decades. The mergers and acquisitions are also the options available for top firms to catch the market and earn more business.
Target Audience:
Manufacturers, Hospital and Clinics, Distributors/Suppliers/Wholesalers, Government Sector, Research Firms and Downstream Vendors
Major Objectives Focused through this Study
To define, describe, and forecast the Global Crisaborole market on the basis of product [Purity of less than 98% and More than or equal to 98%] , application [Allergic dermatitis, Eczema and Others], key regions and end user
To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
To provide market size for various segments of the Crisaborole market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
To strategically profile the key players and analyzing their market shares and core competencies in the Crisaborole industry
To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market
Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are Hangzhou Longshine Bio-Tech (China) and LGM Pharma (United States).
** Confirmation on availability of data would be informed prior purchase
While framing the research framework, major and emerging players operating in the Crisaborole market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.